Drugs / Ipratroium
last change Mar 2024 re-read 2 minutes ago

Ipratroium

Developed for
chronic obstructive pulmonary disease
Investigated by
Assiut University

Trials 1 · a red edge is where a trial was stopped

202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT05748977 Feb 2023 → Feb 2024 chronic obstructive pulmonary disease Assiut University Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Ipratroium “Inhaled Fenotereol,Ipratroium Plus Beclomethasone Versus Salmeterol,Tiotropium Plus Fluticasone” NCT05748977
Route Inhaled Inhaled Fenotereol,Ipratroium Plus Beclomethasone Versus Salmeterol,Tiotropium Plus Fluticasone” NCT05748977